Evaluation of risk-tailored individualized selection of radiation therapy target volume for head and neck carcinoma of unknown primary.
Ghatasheh H, Huang SH, Su J, Xu W, Bratman SV, Cho J, Giuliani M, Hahn E, Hope A, Kim J, O'Sullivan B, Ringash J, Waldron J, Chepeha DB, Irish JC, Goldstein DP, Spreafico A, Tong L, de Almeida JR, Hosni A.
Ghatasheh H, et al.
Radiother Oncol. 2022 Oct;175:56-64. doi: 10.1016/j.radonc.2022.07.016. Epub 2022 Jul 26.
Radiother Oncol. 2022.
PMID: 35905781